![Gavin Malenfant](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gavin Malenfant
Geschäftsführer bei PROMIS NEUROSCIENCES, INC.
Vermögen: 4 900 $ am 31.05.2024
Aktive Positionen von Gavin Malenfant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROMIS NEUROSCIENCES, INC. | Geschäftsführer | 22.10.2021 | - |
Karriereverlauf von Gavin Malenfant
Ehemalige bekannte Positionen von Gavin Malenfant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GMalenfant Consulting LLC | Gründer | 01.05.2018 | 01.10.2021 |
AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2016 | 01.05.2018 |
SAREPTA THERAPEUTICS, INC. | Geschäftsführer | 01.05.2015 | 01.01.2016 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Geschäftsführer | - | - |
Ausbildung von Gavin Malenfant
University of Massachusetts Boston | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Kanada | 2 |
Operativ
Chief Operating Officer | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
PROMIS NEUROSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
GMalenfant Consulting LLC |
- Börse
- Insiders
- Gavin Malenfant
- Erfahrung